EMD-39839

Single-particle
3.87 Å
EMD-39839
3D View Gallery
Deposition: 21/04/2024
Map released: 12/02/2025
Last modified: 18/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-39839

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8z86 summary report (pdf.gz) Map-8z86 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BA.5 RBD in complex with CR9

EMD-39839

Single-particle
3.87 Å
EMD-39839
3D View Gallery
Deposition: 21/04/2024
Map released: 12/02/2025
Last modified: 18/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: BA.5 RBD in complex with CR9
Fitted models: 8z86

Deposition Authors: Feng LL
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.
Chen Z, Feng L, Wang L, Zhang L, Zheng B, Fu H, Li F, Liu L, Lv Q, Deng R, Xu Y, Hu Y, Zheng J, Qin C, Bao L , Wang X , Jin Q
(2025) Signal Transduct Target Ther , 10 , 14 - 14
PUBMED: 39800731
DOI: doi:10.1038/s41392-024-02114-6
ISSN: 2059-3635
Grant Support: